Exchange: OTC·Updated 03:58 PM EDT
VXRT logo

VXRT Vaxart Inc

$0.4925
$0.002
(0.41%)
Today
Reported EarningsAug 6
Mkt Cap$119.11M
Vol256,912.00

About VXRT

Vaxart, Inc. is a clinical-stage biotechnology company, which engages in the development of oral recombinant vaccines based on its Vector-Adjuvant-Antigen Standardized Technology (VAAST) oral vaccine platform. It is developing prophylactic vaccine candidates that target a range of infectious diseases, including SARS-CoV-2, norovirus, seasonal influenza and respiratory syncytial virus (RSV). The company was founded by Sean Tucker in March 2004 and is headquartered in South San Francisco, CA.
56

Bullish Sentiment

How do you feel about VXRT?

Advertisement|Remove ads.